Skip to main content
Gastroenterology
Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease.
Changing Paradigms in Detection of Dysplasia and Management of Patients With Inflammatory Bowel Disease: Is Colectomy Still Necessary?
Detectable Drug Levels in Infants Exposed to Biologics: So What?
Sa1885 Incidence of and Predictors for Early Discontinuation of Biologic Therapies in Veteran Patients with Inflammatory Bowel Disease.
352 Sex Differences in Acetaminophen-Induced Acute Liver Injury and Acute Liver Failure.
245 A20 and ABIN-1 Cooperate to Restrict Intestinal Epithelial Cell Death and Maintain Mucosal Immune Homeostasis.
Minimal Transplant Survival Benefit for Hepatocellular Carcinoma: Is it Real or an Overestimation of Waitlist Life Expectancy?
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy.
Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B.
Mutation spectrum and risk of colorectal cancer in African American families with Lynch syndrome.